Topeka ER & Hospital brings MeMed BV Diagnostic Technology to Topeka Community

Topeka ER & Hospital, a physician-managed hospital designed to provide community access to prompt, compassionate emergency care, announces that they have partnered with MeMed to adopt the trailblazing MeMed BV® test that distinguishes viral from bacterial infection within 15 minutes.

MeMed BV is a diagnostic test developed to address the management of patients with acute infection in different clinical settings, including the emergency department. The MeMed BV test uses machine learning to integrate measurements of three key host-immune proteins into a score indicating the likelihood of bacterial or viral infections. The ability to distinguish between bacterial and viral infections early in the diagnostic process has significant potential to impact patient care and combat antimicrobial resistance.

“Topeka ER & Hospital is proud to announce the latest addition to our state-of-the-art diagnostic laboratory technology, the MeMed BV test”, said Dr. Jared Schreiner, Chief Medical Officer and ER Physician at Topeka ER & Hospital. “Symptoms of bacterial and viral infections are often clinically indistinguishable, which creates a challenge for physicians when deciding whether to treat a patient with antibiotics. This FDA-cleared immunoassay test will assist our clinicians in deciphering between infections and accurate treatment plans.”